Journal of Cancer 2014, Vol[removed]

First Page		Document Content
Date: 2014-05-21 06:25:53 Neuroendocrine tumor Non-small-cell lung carcinoma Nintedanib Vascular endothelial growth factor Metastasis Hypoxia-inducible factors Adenocarcinoma Carcinogenesis Carcinoid Medicine Oncology Lung cancer		Journal of Cancer 2014, Vol[removed] Add to Reading List Source URL: www.jcancer.org Download Document from Source Website File Size: 496,66 KB Share Document on Facebook

	Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl DocID: 1qEY9 - View Document
	Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio DocID: 1pKF2 - View Document
	Bijsluiter: informatie voor de patiënt Ofev® 150 mg zachte capsules Nintedanib Dit geneesmiddel is onderworpen aan aanvullende monitoring. Daardoor kan snel nieuwe veiligheidsinformatie worden vastgesteld. U kunt hiera DocID: 1lWvH - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. OFEV® (nintedanib) capsules, for oral use I DocID: 1lf9I - View Document
	Bijsluiter: informatie voor de patiënt Vargatef 100 mg zachte capsules nintedanib Dit geneesmiddel is onderworpen aan aanvullende monitoring. Daardoor kan snel nieuwe veiligheidsinformatie worden vastgesteld. U kunt hie DocID: 1kOm2 - View Document